Skip to main content
Medical Journal of the Islamic Republic of Iran logoLink to Medical Journal of the Islamic Republic of Iran
. 2020 May 4;34:43. doi: 10.34171/mjiri.34.43

Analysis of KRT5 and KRT14 gene mutations and mode of inheritance in Iranian patients with clinical suspicion of Epidermolysis bullosa simplex

Pouria Khani 1, Siamak Farokh Forghani 2, Zohreh Ataei Kachoei 1, Ali Zekri 1,*, Farideh Ghazi 1,*
PMCID: PMC7456439  PMID: 32884918

Abstract

Background: Epidermolysis bullosa simplex is a hereditary skin disorder caused by mutations in several genes such as KRT5 and KRT14 . Skin fragility in basal keratinocytes presence regions led to the cytolysis of epidermis and blistering. Aim of this study was to detect the molecular defects in KRT5 and KRT14 genes hot spots in patients with clinical suspicion of EBS and investigation of their probable genotype-phenotype correlations.

Methods: Exons 1 and 6-7 of KRT5 and exons 1 and 4-7 of KRT14 amplification and mutation detection were performed by polymerase chain reaction and Sanger sequencing, respectively. Novel variants pathogenicity evaluated by bioinformatics tools.

Results: Nine important variants detected in seven different patients within 6 Iranian families affected by Epidermolysis bullosa simplex, of which four variants were novel. Three patients had a mottled pigmentation phenotype [G96D (p.Gly96Asp) and F97I (p.Phe97Ile) in KRT5 ]. One of them showed a Dowling–Meara phenotype [A417P (p.Ala417Pro) and E477D (p.Glu477Asp) in KRT5 ] and another had a Koebner type phenotype [R397I (p.Arg397Ile) and Q444* (p.Gln444Ter) in KRT5 ]. A novel variant [G92E (p.Gly92Glu) in KRT5 ] in a double heterozygous state with a challenging variant [A413T (p.Ala413Thr) in KRT14 ] identified in one patient with Koebner type phenotype. Also, a previously reported mutation [I377T (p.Ile377Thr) in KRT14 gene] identified in this study.

Conclusion: The results of molecular data analysis showed that the most severe phenotypes were associated with mutations in highly conserved regions. In some cases, different inheritance modes were observed.

Keywords: Epidermolysis bullosa simplex, Skin fragility, Keratin


↑ What is “already known” in this topic:

Epidermolysis bullosa simplex (EBS) is one of the most common genetic bullous skin diseases characterized by the separation of the skin at the basal keratinocytes region after trauma and blister formation. The most important and most commonly occurring molecular defects in these patients are the defects of keratins 5 and14 (KRT5 and KRT14).

→ What this article adds:

Exons 1 and 6-7 of KRT5 and exons 1 and 4-7 of KRT14 mutation detection were performed in this study. The results of molecular analyzing showed that the most severe phenotypes were associated with mutations in highly conserved regions. In some cases, different inheritance modes were observed. These mutations showed regional variations useful in genetic counseling and prenatal testing in different ethnic groups. Our data demonstrated the heterogenic status of KRT5 and KRT14 genes mutations.

Introduction

Epidermolysis bullosa simplex (EBS) is a group of genodermatoses characterized by fragility of the skin and separation of tissue through basal keratinocytes that resulted in intraepidermal blistering upon mild mechanical trauma (1). Among all EB cases, the most common subtype is EBS, with an approximate prevalence of 1 in 25 000–50 000 (2, 3). However, the prevalence of EBS in Iran remains unknown. Localized EBS (the mildest form), generalized intermediate EBS, EBS-with mottled pigmentation and generalized severe EBS (Dowling-Meara type) are the most common subtypes of EBS (4, 5).

The underlying mutations in EBS are mostly affected by KRT5 and KRT14. These genes encode keratin 5 (K5) and 14 (K14) that typically expressed in the epidermal basal layer (6, 7). Keratin filaments are part of cytoskeletal intermediate filament proteins. Interactions between keratin 5 and 14 filaments using their α-helical rod domains to bundle formation have essential roles for strength and flexibility to basal keratinocytes and maintenance of epidermis integrity and resilience against physical traumas (7-10). Recessive mutations are usually reported in KRT14 gene, while dominant mutations (especially missense mutations) have been seen in both genes (11-13). In the Western world (with a low prevalence of consanguineous marriage) remarkable proportion of EBS cases have autosomal dominant inheritance pattern, whereas in regions or countries with a high prevalence of inbreeding, autosomal recessive inheritance is more prevalent (11, 14). Through analysis of phenotype-genotype correlation has been revealed that mutation in highly conserved regions in keratin molecule (two terminals of the central rod section) is usually related to a severe phenotype (generalized severe EBS). Mutations in less conserved areas are related to milder phenotypes (e.g., Localized EBS) (15-17). Moreover, the nature of the amino acid alteration affects the severity of the disease (18, 19).

In this study, we carried out the analysis of molecular genetics of keratin mutations in 12 families of Iranian patients suspected to Epidermolysis bullosa simplex to investigate the mode of inheritance and correlation between genotype-phenotype. At the end of this study, we debate how these molecular alterations create different phenotypic manifestations.

Methods

Patient selection: According to precise clinical examinations, family history and pattern of inheritance, 15 patients in 12 families diagnosed with EBS. Criteria of diagnosis for patient selection and their classification were based on the report of the Third international consensus meeting on diagnosis and classification of Epidermolysis bullosa (20). After approval by the Medical Ethics Committee of Iran University of Medical Sciences, all patients and their families contributed to this study with fully informed consent for sample collection and sequencing of DNA. Then 5 ml of blood was collected into Ethylenediaminetetraacetic acid tubes from patients and their relatives.

PCR and Mutation detection: Genomic DNA was isolated from peripheral blood leukocytes using the salting-out method (21). Polymerase chain reaction (PCR) amplification of KRT5 exons 1, 6-7, KRT14 exons 1, 4-7 and their flanking intronic sequences performed. The sequence of primers used for PCR amplification of the specific amplicons was described previously (Table 1) (22). Each PCR reaction was contained 12.5 µl of PCR master mix, 2.5 µl of genomic DNA (Approximately 100-150 ng of DNA), 0.4µl of forward primer (with a concentration of 10 pmol/ul), 0.4µl of reverse primer (with a concentration of 10 pmol/ul) and 9.2µl of double-distilled water. Initial denaturation at 94 0C for 5 min and then 30 amplification cycles were performed with a program contained 1 min at 94 0C, 1 min at 60 0C and 1 min at 72 0C with a final incubation of 5 min at 72 0C for all of the exons were the same except primers of KRT14 exon 4-7 that their annealing temperature was 63 0C (to avoid amplification of the KRT14 pseudogene). PCR Products purified and sequenced (using ABI 3730XL DNA Sequencer by Macrogen Company). For the detection of mutations, PCR product sequences were compared with sequences obtained from GenBank accession number NM_000424.3 as a reference sequence for KRT5 and GenBank accession number NM_000526.3 as a reference sequence for KRT14 (http://www.ncbi.nlm.nih.gov/).

Table1. Primers and their sequences .

Gene / exon Primer ( Sequence 5’ to 3’ )
Forward Reverse
KRT5/e1 AGCTCTGTTCTCTCCAGCAC CAGTCTAATTCAGAACGTGTCC
KRT5/e6-7 TCACTGCCTGTGAACTTTGG GGCCATGAGTCAGACTGAAA
KRT14/e1 TTACCCGAGCACCTTCTCTTC TGCTGGAGAACAAGTAGCTGC
KRT14/e4-7 GGCCTAAGGAACACCAATCC CACTAGAGCTCAGCCCCTCA

Results

Phenotypic observations: From the 12 families, 15 affected individuals were clinically evaluated (Table 2). An explicit EBS-DM (Dowling–Meara) phenotype in four probands from 4 unrelated families and an ambiguous phenotype in an intermediate mode between Dowling–Meara and Koebner type in one patient (patient 5) were observed. Three patients from 2 unrelated families showed EBS with mottled pigmentation phenotype. Five patients from 3 different families had a Koebner type of EBS. Also, 2 patients in 2 separate families showed a Weber‐Cockayne phenotype. The eldest and youngest patients were 48 and 4 years old, respectively. The prevalence of consanguineous marriages among the selected families was 58.3% and families were from several different Iranian ethnic groups. Clinical features of patients have been shown in Figure 1.

Table 2. Families, patients and their features .

Family Patient Sex Age Phenotype Clinical features
1 1 Female 52 mottled pigmentation Spontaneous blistering after a minor trauma
Nail dystrophy (Fig. 2a)
Reticulate skin pigmentation
Keratoderma
2 Male 27
2 3 Male 7 Dowling–Meara Onset age: at birth
Blisters in herpetiform clusters on the trunk and proximal extremities
Nail dystrophy and then nail losing
Mucosal involvement: esophagus
Teeth involvement
3 4 Male 10 Koebner type Onset age: early infancy
Blistering after minor trauma (Fig. 2c)
Mucosal involvement
Teeth involvement
Nail losing
Hyperkeratosis of the palms and soles
4 5 Male 48 Dowling–Meara Onset age: at birth
Nail dystrophy (Fig. 2b) and then nail losing
Mucosal involvement: esophagus
Teeth involvement
Hypopigmentation and hyperpigmentation (Fig. 2b)
5 6 Male 36 Weber‐Cockayne Onset age: adolescence
Blistering: typically restricted to hands and feet
Healing of blisters with minor scarring
6 7 Male 6 Weber‐Cockayne
And
Koebner type
Onset age: early infancy
Blistering in whole body surface that typically restricted to hands and feet (after a minor trauma)
Mucosal involvement
Nail losing (2 fingers)
7 8 Female 8 Dowling–Meara Onset age: at birth
Blisters in herpetiform clusters on the trunk and proximal extremities
Nail dystrophy and then nail losing
Mucosal involvement: esophagus
Progressive hyperkeratosis of the palms
8 9 Female 8 Dowling–Meara Onset age: at birth
Blisters in herpetiform clusters on the trunk and proximal extremities
Nail losing
Mucosal involvement: esophagus
Milia
9 10 Female 12 Dowling–Meara Onset age: at birth
Generalized blistering
Mucosal involvement: esophagus
Progressive hyperkeratosis of the palms
Nail losing
Milia
Progressive hyperkeratosis of the soles
10 11 Male 24 Koebner type Onset age: early infancy
Nail dystrophy and then nail losing
Mucosal involvement: esophagus
Hypopigmentation and hyperpigmentation
Hyperkeratosis of the palms and soles
12 Male 31
13 Male 22
11 14 Female 41 Koebner type Onset age: early infancy
Generalized blistering after a minor trauma
Nail losing
Teeth involvement
Mucosal involvement
Hypopigmentation and hyperpigmentation
12 15 Female 38 mottled pigmentation Onset age: at birth
Occasionally Skin blistering: restricted to hands and feet
Reticulate skin pigmentation

Fig.1.

Fig.1

Some clinical features of patients. a: toe nail dystrophy in patient 1; b: nail dystrophy and then nail losing, Hypopigmentation and hyperpigmentation in patient 5; c: blistering scar in the sole of the foot in patient 4.

Keratin mutation identification: Sequence analysis of the KRT5 and KRT14 genes revealed 9 variants that are listed in Table 3 and Figure 2. Four variants have not been reported previously and five are known. 8 of 9 variants were missense and one was nonsense. Four novel variants with probable pathologic importance in KRT5 were c.289T>A in exon 1(patients 1, 2 and 15), c.1190G>T in exon 6 and c.1330C>T in exon 7(patient 14), c.1249G>C in exon 7(patient 5). Despite the previous report from two variants [c.287G>A and c.275G>A in exon 1 of KRT5], no association has been reported between EBS and these variants so far. Three formerly reported mutations, also detected (two in exon 6 of KRT14: c.1130T>C (patient 7), c.1237G>A (patient 4) and c.1431G>C in exon 7 of KRT5 (patient 5)).

Table 3. All variants found in the KRT5 and KRT14 genes in this study .

Patient Effect on coding sequence HGVS coding HGVS Protein level
KRT5
1 and 2 Missense c.287G>A G96D
1,2 and 15 Missense c.289T>A (N) F97I
4 Missense c.275G>A G92E
14 Missense c.1190G>T (N) R397I
14 Nonsense c.1330C>T (N) Q444*
5 Missense c.1249G>C (N) A417P
5 Missense c.1431G>C E477D
KRT14
7 Missense c.1130T>C I377T
4 Missense c.1237G>A A413T

Fig. 2.

Fig. 2

Schematic picture from variants in KRT5 and KRT14 genes. a: KRT5 exons and protein; b: KRT14 exons and protein

Discussion

In this study, we identified 9 important variants. Among the identified variants, four of them were not reported previously (Table 3).

In family 1 (patients 1 and 2), a mother and her son affected by EBS showed mottled pigmentation phenotype with an autosomal dominant inheritance. Interestingly, their clinical features (Table 2) were modified and reduced symptom severity over time. Two heterozygous variants identified in KRT5 gene were located within the head domain of keratin 5 protein (Fig. 2a). Since the mutations in this region appeared to be consistent with mottled pigmentation phenotype, therefore a genotype-phenotype correlation was observed (23). The first variant, which is considered as a disease-causing variant, is c.287G>A with G96D (p.Gly96Asp) effect. According to the ACMG guideline, this variant is considered as an Uncertain Significance by getting scores PP3, PP4 (due to patient’s phenotype highly specific for the gene) and PM2 (because of this variant absent in South Asian population). The other variant (c.289T>A with F97I (p.Phe97Ile) effect) was a novel genetic variant. According to the ACMG guidelines by getting score PM2, this variant is considered as Uncertain Significance. Patient 15 (in family 12) had very milder symptoms than family 1 and unexpectedly carried de novo c.289T>A variant. This suggests that this variant has a possible synergic genetic effect with c.287G>A variant.

Patient 4 (in family 3) was one of the interesting cases in this study because of having a double heterozygous state for KRT5 and KRT14 genes. His clinical features were concordant with EBS, Koebner type. An important identified variant was c.1237G>A in KRT14 gene. First report of this variant was in a Taiwanese patient with EBS, Koebner type (24). However, in the study conducted by Ken Natsuga et al. (25), in a Japanese family, three normal Japanese had c.1237G>A transition (p.Ala413Thr) within KRT14 and they did not have any history of skin fragility or nail dystrophy. But what is more challenging, is a case report of EBS, Koebner type (generalized intermediate) by Wakiguchi et al. (26), which is a double heterozygote patient; it is described that one of the causative mutations was c.1237G>A (p.Ala413Thr) in KRT14 and another mutation in KRT5. In the mentioned study, mother and sister of the patient were asymptomatic and carried c.1237G>A in the KRT14 gene, but no mutation in KRT5 gene. Another important variant found in patient 4, was c.275G>A in KRT5 gene with G92E (p.Gly92Glu) effect. This variant is located in the head domain of keratin 5 protein (Fig. 2a) and according to the ACMG guideline, considered as Uncertain Significance (because of two scores: PP3 and PM2). However, it is important to note that c.1237G>A in KRT14 is located in the terminal site of the helix2B motif (IF rod) (Fig. 2b) and is concordant with the phenotype of the patient. Therefore the presence of these two variants maybe suggested a digenic pattern of inheritance.

An unequivocal Koebner type phenotype was observed in patient 14(in family 11). Mutation analysis revealed two novel variants in KRT5 gene in a compound heterozygous state and an autosomal recessive inheritance in this patient. Both of these variants are located in the helix 2B motif (IF rod domain) of keratin5 protein (Fig. 2a) that is concordant with the patient's phenotype (genotype-phenotype correlation). The first variant is a nonsense variant (c.1330C>T) in exon 7 of KRT5 with Q444* (p.Gln444Ter) effect. c.1330C>T in KRT5 by getting PM1, PM2, PP3 and PVS1 ACMG scores classified as a Pathogenic variant. Another novel variant is c.1190G>T (p.Arg397Ile) in exon 6 of KRT5. ACMG scores for this variant are PM1, PM2, and PP3 that fall into the Uncertain Significance category.

An unclear intermediate phenotype between Dowling–Meara and Koebner type was characterized by a probable autosomal recessive inheritance that was observed in patient 5. This patient was compound heterozygous for both variants c.1249G>C and c.1431G>C in KRT5 gene. Both were located at the helix 2B motif (IF rod domain) of keratin 5 protein (Fig. 2a) and they were correlated with Dowling–Meara patient's phenotype. c.1249G>C was a novel variant (being PM1, PM2 and PP3) and considered as an Uncertain Significance. c.1431G>C transition in KRT5 (E477D (p.Glu477Asp)) in a heterozygous state was previously reported in a patient with EB simplex Dowling–Meara accompanied by verrucous carcinoma (27). However, a study by Homberg M et al. (28), suggested that E477D in Keratin 5 for causing severe generalized EBS requires genetic modifiers. The probable genetic modifier for this phenotype in patient 5 can be 1249G>C variant.

The c.1130T>C transition in exon 6 of KRT14 gene (I377T (p.Ile377Thr)) was found in a homozygous state in patient 7(in family 6). This mutation was first previously reported by Rugg EL et al. (29) in a patient with localized EBS (Weber‐Cockayne) and subsequently, in 2016, it was described by Vahidnezhad H et al. (30) in a large Iranian family with a high degree of consanguineous marriage. According to their observations, semi-dominant inheritance was suggested for this genetic alteration and its impacts (30). However, in this study, the patient's clinical features (Table 2) were severe while his mother and father were asymptomatic (only have minor blisters in the sole of the foot after a long walking). Therefore, it was difficult to determine the inheritance pattern. However, it appears that the homozygous state caused Koebner type; and the heterozygous state developed Weber‐Cockayne.

In this study, 15 EBS patients were screened for sequence variation in exons 1, 6-7 of KRT5 and exons 1, 4-7 of KRT14. Seven of them were described at the molecular level. Patients with no variation in mentioned exons might have mutations in other exons of KRT5 and KRT14 or other genes with overlapping phenotypes such as PLEC,COL17A1 and ITGB4 (23, 31). Moreover, para mutations as epigenetic phenomena may also be involved in the pathogenesis of EBS (32).

Conclusion

We found 9 important variants in KRT5 and KRT14 genes. According to Our data, for rapid mutation screening of EBS, we recommend mutation analysis of the hotspots of these genes. Genotype-phenotype correlation can be useful for the interpretation of molecular variants. Finally, next generation sequencing can be an alternative method for mutation detection and copy number variation analysis in patients with EBS.

Acknowledgments

This study was supported by a research committee foundation grant no. 96-01-30-30550 of Iran University of Medical Sciences. We wish to thank the patients and their families for participating in this study, and staff at the department of genetics at Iran University of Medical Sciences.

Conflict of Interests

The authors declare that they have no competing interests.

Cite this article as: Khani P, Farokh Forghani S, Ataei Kachoei Z, Zekri A, Ghazi F. Analysis of KRT5 and KRT14 gene mutations and mode of inheritance in Iranian patients with clinical suspicion of Epidermolysis bullosa simplex. Med J Islam Repub Iran. Med J Islam Repub Iran. 2020 (4 May);34:43. https://doi.org/10.34171/mjiri.34.43

References

  • 1.Gu LH, Coulombe PA. Keratin function in skin epithelia: a broadening palette with surprising shades. Curr Opin Cell Biol. 2007;19(1):13–23. doi: 10.1016/j.ceb.2006.12.007. [DOI] [PubMed] [Google Scholar]
  • 2.Gedde-Dahl T, Anton-Lamprecht I. Epidermolysis bullosa. Emery and Rimoin's principles and practice of medical genetics. 1996;1:1225–78. [Google Scholar]
  • 3.Horn H, Priestley G, Eady R, Tidman M. The prevalence of epidermolysis bullosa in Scotland. Br J Dermatol. 1997;136(4):560–4. [PubMed] [Google Scholar]
  • 4.Coulombe PA, Hutton ME, Letal A, Hebert A, Paller AS, Fuchs E. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell. 1991;66(6):1301–11. doi: 10.1016/0092-8674(91)90051-y. [DOI] [PubMed] [Google Scholar]
  • 5.Lane E, Rugg E, Navsaria H, Leigh I, Heagerty A, Ishida-Yamamoto A. et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature. 1992;356(6366):244. doi: 10.1038/356244a0. [DOI] [PubMed] [Google Scholar]
  • 6.Bonifas J, Rothman A, Epstein E. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science. 1991;254(5035):1202–5. doi: 10.1126/science.1720261. [DOI] [PubMed] [Google Scholar]
  • 7.Kim S, Coulombe PA. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 2007;21(13):1581–97. doi: 10.1101/gad.1552107. [DOI] [PubMed] [Google Scholar]
  • 8.Coulombe PA, Kerns ML, Fuchs E. Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility. J Clin Invest. 2009;119(7):1784–93. doi: 10.1172/JCI38177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Herrmann H, Strelkov SV, Burkhard P, Aebi U. Intermediate filaments: primary determinants of cell architecture and plasticity. J Clin Invest. 2009;119(7):1772–83. doi: 10.1172/JCI38214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Arin MJ. The molecular basis of human keratin disorders. Hum Genet. 2009;125(4):355–73. doi: 10.1007/s00439-009-0646-5. [DOI] [PubMed] [Google Scholar]
  • 11.Ciubotaru D, Bergman R, Baty D, Indelman M, Pfendner E, Petronius D. et al. Epidermolysis bullosa simplex in Israel: clinical and genetic features. Arch Dermatol. 2003;139(4):498–505. doi: 10.1001/archderm.139.4.498. [DOI] [PubMed] [Google Scholar]
  • 12.Szeverenyi I, Cassidy AJ, Chung CW, Lee BT, Common JE, Ogg SC. et al. The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum Mutat. 2008;29(3):351–60. doi: 10.1002/humu.20652. [DOI] [PubMed] [Google Scholar]
  • 13.Yiasemides E, Trisnowati N, Su J, Dang N, Klingberg S, Marr P. et al. Clinical heterogeneity in recessive epidermolysis bullosa due to mutations in the keratin 14 gene, KRT14. Clin Exp Dermatol. 2008;33(6):689–97. doi: 10.1111/j.1365-2230.2008.02858.x. [DOI] [PubMed] [Google Scholar]
  • 14.Sa'd JA, Indelman M, Pfendner E, Falik-Zaccai TC, Mizrachi-Koren M, Shalev S. et al. Molecular epidemiology of hereditary epidermolysis bullosa in a Middle Eastern population. J Invest Dermatol. 2006;126(4):777–81. doi: 10.1038/sj.jid.5700163. [DOI] [PubMed] [Google Scholar]
  • 15.Uitto J, Richard G. Progress in epidermolysis bullosa: from eponyms to molecular genetic classification. Clin Dermatol. 2005;23(1):33–40. doi: 10.1016/j.clindermatol.2004.09.015. [DOI] [PubMed] [Google Scholar]
  • 16. Uitto J, Richard G, editors. Progress in epidermolysis bullosa: genetic classification and clinical implications. Am J Med Genet C Semin Med Genet 2004: Wiley Online Library. [DOI] [PubMed]
  • 17.Liovic M, Stojan J, Bowden PE, Gibbs D, Vahlquist A, Lane EB. et al. A novel keratin 5 mutation (K5V186L) in a family with EBS-K: a conservative substitution can lead to development of different disease phenotypes. J Invest Dermatol. 2001;116(6):964–9. doi: 10.1046/j.1523-1747.2001.01334.x. [DOI] [PubMed] [Google Scholar]
  • 18.Sørensen CB, Ladekjær-Mikkelsen AS, Andresen BS, Brandrup F, Veien NK, Buus SK. et al. Identification of novel and known mutations in the genes for keratin 5 and 14 in Danish patients with epidermolysis bullosa simplex: correlation between genotype and phenotype. J Invest Dermatol. 1999;112(2):184–90. doi: 10.1046/j.1523-1747.1999.00495.x. [DOI] [PubMed] [Google Scholar]
  • 19.Murrell DF, Trisnowati N, Miyakis S, Paller AS. The yin and the yang of keratin amino acid substitutions and epidermolysis bullosa simplex. J Invest Dermatol. 2011;131(9):1787–90. doi: 10.1038/jid.2011.206. [DOI] [PubMed] [Google Scholar]
  • 20.Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A. et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008;58(6):931–50. doi: 10.1016/j.jaad.2008.02.004. [DOI] [PubMed] [Google Scholar]
  • 21.Nasiri H, Forouzandeh M, Rasaee M, Rahbarizadeh F. Modified salting‐out method: high‐yield, high‐quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal. 2005;19(6):229–32. doi: 10.1002/jcla.20083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.García M, Santiago J, Terrón A, Hernández‐Martín A, Vicente A, Fortuny C. et al. Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex. Br J Dermatol. 2011;165(3):683–92. doi: 10.1111/j.1365-2133.2011.10428.x. [DOI] [PubMed] [Google Scholar]
  • 23.Khani P, Ghazi F, Zekri A, Nasri F, Behrangi E, Aghdam AM. et al. Keratins and epidermolysis bullosa simplex. J Cell Physiol. 2018;234(1):289–97. doi: 10.1002/jcp.26898. [DOI] [PubMed] [Google Scholar]
  • 24.Chao SC, Yang MH, Lee SF. Novel KRT14 mutation in a Taiwanese patient with epidermolysis bullosa simplex (Kobner type) J Formos Med Assoc. 2002 Apr;101(4):287–90. [PubMed] [Google Scholar]
  • 25.Natsuga K, Nishie W, Smith BJ, Shinkuma S, Smith TA, Parry DA. et al. Consequences of two different amino-acid substitutions at the same codon in KRT14 indicate definitive roles of structural distortion in epidermolysis bullosa simplex pathogenesis. J Invest Dermatol. 2011 Sep;131(9):1869–76. doi: 10.1038/jid.2011.143. [DOI] [PubMed] [Google Scholar]
  • 26.Wakiguchi H, Hasegawa S, Maeba S, Kimura S, Ito S, Tateishi H. et al. A Sporadic Neonatal Case of Epidermolysis Bullosa Simplex Generalized Intermediate with KRT5 and KRT14 Gene Mutations. AJP Rep. 2016 Mar;6(1):e108–11. doi: 10.1055/s-0035-1570386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Schumann H, Roth W, Has C, Volz A, Erfurt-Berge C, Magin TM. et al. Verrucous carcinoma in epidermolysis bullosa simplex is possibly associated with a novel mutation in the keratin 5 gene. Br J Dermatol. 2012 Oct;167(4):929–36. doi: 10.1111/j.1365-2133.2012.11075.x. [DOI] [PubMed] [Google Scholar]
  • 28.Homberg M, Ramms L, Schwarz N, Dreissen G, Leube RE, Merkel R. et al. Distinct impact of two keratin mutations causing epidermolysis bullosa simplex on keratinocyte adhesion and stiffness. J Invest Dermatol. 2015;135(10):2437–45. doi: 10.1038/jid.2015.184. [DOI] [PubMed] [Google Scholar]
  • 29.Rugg EL, Horn HM, Smith FJ, Wilson NJ, Hill AJ, Magee GJ. et al. Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations. J Invest Dermatol. 2007;127(3):574–80. doi: 10.1038/sj.jid.5700571. [DOI] [PubMed] [Google Scholar]
  • 30.Vahidnezhad H, Youssefian L, Saeidian AH, Mozafari N, Barzegar M, Sotoudeh S. et al. KRT5 and KRT14 Mutations in Epidermolysis Bullosa Simplex with Phenotypic Heterogeneity, and Evidence of Semidominant Inheritance in a Multiplex Family. J Invest Dermatol. 2016;136(9):1897. doi: 10.1016/j.jid.2016.05.106. [DOI] [PubMed] [Google Scholar]
  • 31.Koss‐Harnes D, Jahnsen F, Wiche G, Soyland E, Brandtzaeg P, Gedde‐Dahl Jr T. Plectin abnormality in epidermolysis bullosa simplex Ogna: non‐responsiveness of basal keratinocytes to some anti‐rat plectin antibodies. Exp Dermatol. 1997;6(1):41–8. doi: 10.1111/j.1600-0625.1997.tb00144.x. [DOI] [PubMed] [Google Scholar]
  • 32.Cuzin F, Grandjean V, Rassoulzadegan M. Inherited variation at the epigenetic level: paramutation from the plant to the mouse. Curr Opin Genet Dev. 2008;18(2):193–6. doi: 10.1016/j.gde.2007.12.004. [DOI] [PubMed] [Google Scholar]

Articles from Medical Journal of the Islamic Republic of Iran are provided here courtesy of Iran University of Medical Sciences

RESOURCES